Last update: September 06th 2016
August 31th 2016

EMA’s report on adaptive pathways: little data...

A joint press release issued by ISDB, MiEF and Nordic Cochrane Centre regarding the recently published report on EMA's controversial "adaptive pathways" pilot project. The report includes no new factual data, with no information shared about the drug's indications, type...

December 23th 2015

A PRIME example of how EMA is pushing for...

Joint response of Health Action International (HAI), International Society of Drug Bulletins (ISDB), Mario Negri Institute for Pharmacological Research, Medicines in Europe Forum (MiEF), Nordic Cochrane Centre and Wemos to the European Medicines Agency (EMA) public consultation on the...

October 16th 2015

"Adaptive licensing" or "adaptive pathways":...

Joint briefing paper from Health Action International (HAI), The International Society of Drug Bulletins (ISDB), The Medicines in Europe Forum (MiEF), The Mario Negri Institute for Pharmacological Research, The Nordic Cochrane Centre and WEMOS.

"Adaptive pathways"...

March 20th 2015

European Directive on trade secrets: the JURI...

Joint open Letter to the members of the JURI Committee from the Corporate Europe Observatory (CEO), The Medicines in Europe Forum (MiEF) and The International Society of Drug Bulletins (ISDB) calling on the members of the JURI Committee to ensure, through additional and more ambitious...

for members only

Application for membership

    Country

  1. Applicant

  2. Reference Organization

  3. Institutional status of this organization: (e.g. not-for-profit company, for-profit company, foundation, individual etc)
  4. Origin of reference organization's financial resources
  5. Bulletin funds

  6. Origin of the financial resources
  7. Approximate budget allocation between staff, printing and distribution costs
  8. Conflict of interest

  9. Are there financial links with industry?
    Chief
    Managers
    Staff members
    Collaborators / authors
  10. Publication

  11. In what format is the publication?
  12. What is the circulation?
  13. Contact details

  14. Mobile phone
  15. Article 10: An application for admission must comprise

    1. two copies of each of the last five consecutive issues of the bulletin preceding the date of application. If the issues do not specify the contents in English then a list of these contents, including keywords, shall be sent with the issues;
    2. If appropriate, an English translation of two articles of your bulletin;
    3. a completed application form;
    4. the admission fee (which will be refunded if the application is not accepted).The Committee may request further information to assist it in making its decision.
      Budget of Bulletin Membership fee
      below 30.000 Euro 225 Euro
      over 30.000 Euro 900 Euro
      Developing country 45 Euro (It is possible to apply for exemption when payment is difficult.)

ISDB - International Society of Drug bullettins

Contact details:
President: president@isdbweb.org
Webmaster: maria.font@ulss20.verona.it

© 2017